As a whole and concluding, our findings suggest that PARP inhibition may be a promising strategy against GBM, as PARPi decreases cell viability [12] down-regulates pro-survival pathways and importantly, compromises the GICs population stability (Figure 6). This evidence concerns the gene PARP1 and glioblastoma.